News: NYR Nyrada Says Cholesterol-Lowering Drug Candidate Will Not Be Taken Forward

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    June 26 (Reuters) - Nyrada Inc (NYR) :

    • CHOLESTEROL-LOWERING DRUG CANDIDATE WILL NOT BE TAKEN FORWARD INTO PLANNED PHASE I/IIA CLINICAL TRIAL
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
33.0¢
Change
-0.020(5.71%)
Mkt cap ! $70.65M
Open High Low Value Volume
35.5¢ 35.5¢ 31.0¢ $186.1K 563.6K

Buyers (Bids)

No. Vol. Price($)
2 22852 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 13443 2
View Market Depth
Last trade - 12.54pm 23/07/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.